Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

@article{Marrero2016ObservationalRO,
  title={Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.},
  author={J. A. Fermin Marrero and Masatoshi Kudo and Alan Paul Venook and Sheng-long Ye and J P Bronowicki and Xiao-Ping Chen and Lucy Dagher and Junji Furuse and Jean Francois H Geschwind and Laura Ladr{\'o}n de Guevara and Christos N. Papandreou and Tadatoshi Takayama and Arun J Sanyal and Seung Kew Yoon and Keiko Nakajima and Robert Lehr and Stephanie Heldner and Riccardo A Lencioni},
  journal={Journal of hepatology},
  year={2016},
  volume={65 6},
  pages={
          1140-1147
        }
}
BACKGROUND & AIMS GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) is a prospective, observational registry study evaluating the safety of sorafenib and treatment practices in hepatocellular carcinoma patients. This large global database allowed for assessment of the use and tolerability of sorafenib in patients with liver dysfunction. METHODS Baseline characteristics and medical/treatment history were collected in patients… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 19 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Sorafenib: A Review in Hepatocellular Carcinoma

Targeted Oncology • 2017
View 20 Excerpts
Highly Influenced

Emerging therapies in advanced hepatocellular carcinoma

Experimental hematology & oncology • 2018
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2015
View 1 Excerpt

Current and future treatments for hepatocellular carcinoma

A Schlachterman, WW Craft, +3 authors R. Cabrera
World J Gastroenterol • 2015

Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2015
View 1 Excerpt

Nexavar ® (sorafenib). Summary of product characteristics

AG BayerPharma
Available from: http://www.nexavar.com/scripts/pages/en/home//pdf/Nexavar_SmPC_June_2014.pdf. Accessed • 2015
View 1 Excerpt

Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma

LG DA Fonseca, R Barroso-Sousa, +3 authors TE Pfiffer
2015

Sorafenib in liver function impaired advanced hepatocellular carcinoma.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…